Sonic Innovations to unveil new 12-channel BTE hearing aid at AudiologyNOW! conference

NewsGuard 100/100 Score

Sonic Innovations, Inc. will unveil its new 12-channel super power behind-the-ear (BTE) hearing aid, Endura, at the AudiologyNOW! conference in San Diego, California, April 14 through 17. Endura provides exceptional amplification for those suffering from severe-to-profound hearing loss.

Sonic Innovations CEO Sam Westover said, "With the addition of Endura to our family of products, we offer high quality, cutting-edge products for people with all levels of hearing loss.  Like all of our products, Endura features our patented Sonic Sound digital processing for incredibly natural sound and sophisticated directional systems to improve speech understanding in challenging situations."

With a maximum output of 140 dB SPL, Endura provides enough power to fit even the most profound hearing loss.  Endura has features that include integrated Direct Audio Input and Bluetooth connectivity when paired with the company's sonicBLU accessory.  It also has adaptive and automatic directionality, digital noise reduction, an automatic, hands-free program, four manual programs, 11 predefined listening environments, data logging and voice alerts.

"Endura continues our tradition of offering products designed for modern, active lifestyles." Westover said.

Sonic Innovations' other product lines include Touch (the smallest receiver-in-canal product available in the market), Velocity (premium to affordable hearing aids) and ion (open ear hearing aids).  The Touch microRIC was recently named as the Best of Innovations Design and Engineering Awards winner at the 2010 Consumer Electronics Show.

SOURCE Sonic Innovations, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study tracks long COVID's shifting course in general population